Literature DB >> 24946010

The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression.

Heather Hardin1, Zhenying Guo1, Weihua Shan1, Celina Montemayor-Garcia1, Sofia Asioli2, Xiao-Min Yu3, April D Harrison3, Herbert Chen3, Ricardo V Lloyd4.   

Abstract

Thyroid carcinoma is the most common endocrine malignancy, and papillary thyroid carcinoma represents the most common thyroid cancer. Papillary thyroid carcinomas that invade locally or metastasize are associated with a poor prognosis. We found that, during epithelial-mesenchymal transition (EMT) induced by transforming growth factor-β1 (TGF-β1), papillary thyroid carcinoma cells acquired increased cancer stem cell-like features and the transcription factor paired-related homeobox protein 1 (PRRX1; alias PRX-1), a newly identified EMT inducer, was markedly up-regulated. miR-146b-5p was also transiently up-regulated during EMT, and in siRNA experiments miR-146b-5p had an inhibitory role on cell proliferation and invasion during TGF-β1-induced EMT. We conclude that papillary thyroid carcinoma tumor cells exhibit increased cancer stem cell-like features during TGF-β1-induced EMT, that miR-146b-5p has a role in cell proliferation and invasion, and that PRRX1 plays an important role in papillary thyroid carcinoma EMT and disease progression.
Copyright © 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24946010      PMCID: PMC4116695          DOI: 10.1016/j.ajpath.2014.04.011

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

2.  Identification of an adult stem/progenitor cell-like population in the human thyroid.

Authors:  Alessandra Fierabracci; Maria Ausiliatrice Puglisi; Laura Giuliani; Stefano Mattarocci; Marco Gallinella-Muzi
Journal:  J Endocrinol       Date:  2008-06-11       Impact factor: 4.286

3.  Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas.

Authors:  Darya Buehler; Heather Hardin; Weihua Shan; Celina Montemayor-Garcia; Patrick S Rush; Sofia Asioli; Herbert Chen; Ricardo V Lloyd
Journal:  Mod Pathol       Date:  2012-08-17       Impact factor: 7.842

Review 4.  Clinical review: The emerging cell biology of thyroid stem cells.

Authors:  Terry F Davies; Rauf Latif; Noga C Minsky; Risheng Ma
Journal:  J Clin Endocrinol Metab       Date:  2011-07-21       Impact factor: 5.958

5.  Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion.

Authors:  Vasily Vasko; Allan V Espinosa; William Scouten; Huiling He; Herbert Auer; Sandya Liyanarachchi; Alexander Larin; Victoria Savchenko; Gary L Francis; Albert de la Chapelle; Motoyasu Saji; Matthew D Ringel
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

6.  Emerging functions of microRNA-146a/b in development and breast cancer: microRNA-146a/b in development and breast cancer.

Authors:  Hanan S Elsarraj; Shane R Stecklein; Kelli Valdez; Fariba Behbod
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-02-19       Impact factor: 2.673

7.  Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells.

Authors:  Rebecca S Sippel; Jennifer E Carpenter; Muthusamy Kunnimalaiyaan; Sara Lagerholm; Herbert Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-08       Impact factor: 4.052

8.  The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis.

Authors:  Maximilian Reichert; Shigetsugu Takano; Johannes von Burstin; Sang-Bae Kim; Ju-Seog Lee; Kaori Ihida-Stansbury; Christopher Hahn; Steffen Heeg; Günter Schneider; Andrew D Rhim; Ben Z Stanger; Anil K Rustgi
Journal:  Genes Dev       Date:  2013-01-25       Impact factor: 11.361

9.  Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.

Authors:  Chen-Kai Chou; Kuender D Yang; Fong-Fu Chou; Chao-Cheng Huang; Yueh-Wen Lan; Ya-Fang Lee; Hong-Yo Kang; Rue-Tsuan Liu
Journal:  J Clin Endocrinol Metab       Date:  2012-12-21       Impact factor: 5.958

10.  Growth factor TGF-β induces intestinal epithelial cell (IEC-6) differentiation: miR-146b as a regulatory component in the negative feedback loop.

Authors:  Yalin Liao; Man Zhang; Bo Lönnerdal
Journal:  Genes Nutr       Date:  2012-05-09       Impact factor: 5.523

View more
  43 in total

1.  Long Non-coding RNA Expression in Anaplastic Thyroid Carcinomas.

Authors:  Yanping Wang; Heather Hardin; Ying-Hsia Chu; Karla Esbona; Ranran Zhang; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

2.  Phosphorylated Mechanistic Target of Rapamycin (p-mTOR) and Noncoding RNA Expression in Follicular and Hürthle Cell Thyroid Neoplasm.

Authors:  Adam Covach; Sanjay Patel; Heather Hardin; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

3.  Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.

Authors:  Yamu Li; Wen Wang; Fangyu Wang; Qiushuang Wu; Wei Li; Xiaoling Zhong; Kuan Tian; Tao Zeng; Liang Gao; Ying Liu; Shu Li; Xiaobing Jiang; Guangwei Du; Yan Zhou
Journal:  J Mol Cell Biol       Date:  2017-08-01       Impact factor: 6.216

4.  MiR-146b protects cardiomyocytes injury in myocardial ischemia/reperfusion by targeting Smad4.

Authors:  Yun-Feng Di; De-Cai Li; Yan-Qing Shen; Chun-Lei Wang; Da-Yong Zhang; An-Quan Shang; Teng Hu
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

Review 5.  Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.

Authors:  Ying-Hsia Chu; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

6.  Stage-Specific Embryonic Antigen-1 (SSEA-1) Expression in Thyroid Tissues.

Authors:  Jin Xu; Heather Hardin; Ranran Zhang; Kaitlin Sundling; Darya Buehler; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

7.  MALAT1 Long Non-coding RNA Expression in Thyroid Tissues: Analysis by In Situ Hybridization and Real-Time PCR.

Authors:  Ranran Zhang; Heather Hardin; Wei Huang; Jidong Chen; Sofia Asioli; Alberto Righi; Francesca Maletta; Anna Sapino; Ricardo V Lloyd
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

Review 8.  Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.

Authors:  Heewa Shakib; Sadegh Rajabi; Mohammad Hossien Dehghan; Farideh Jalali Mashayekhi; Nahid Safari-Alighiarloo; Mehdi Hedayati
Journal:  Endocrine       Date:  2019-08-04       Impact factor: 3.633

9.  Gene expression profile of epithelial-mesenchymal transition mediators in papillary thyroid cancer.

Authors:  Ana Lopez-Campistrous; Esther Ekpe Adewuyi; David C Williams; Todd P W McMullen
Journal:  Endocrine       Date:  2020-09-10       Impact factor: 3.633

10.  Generation of Novel Thyroid Cancer Stem-Like Cell Clones: Effects of Resveratrol and Valproic Acid.

Authors:  Heather Hardin; Xiao-Min Yu; April D Harrison; Carolina Larrain; Ranran Zhang; Jidong Chen; Herbert Chen; Ricardo V Lloyd
Journal:  Am J Pathol       Date:  2016-04-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.